Is there a limit to cosentyx dosage for patients over 100 kg?

How does weight affect Cosentyx dosing for adults?

Cosentyx is dosed by weight for some indications. Patients over 100 kg with plaque psoriasis receive 300 mg every four weeks after the initial weekly doses. Patients at or below 100 kg receive 150 mg on the same schedule.

What happens if a patient weighs more than 100 kg but receives the lower dose?

Lower doses in heavier patients have been studied and may reduce effectiveness. The prescribing information directs clinicians to use the higher 300 mg dose for those above 100 kg to achieve the intended response.

When does the 300 mg dose become mandatory?

The 300 mg dose is the labeled recommendation for plaque psoriasis when body weight exceeds 100 kg. It is not an optional escalation; it is the standard regimen in this weight category.

Can Cosentyx dosing be adjusted upward beyond 300 mg?

Prescribing information does not support doses higher than 300 mg. Clinical trials did not evaluate safety or efficacy above this level, so higher amounts are not recommended.

Are there different weight-based rules for other conditions?

For psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, the approved dose is 150 mg regardless of weight. The 300 mg option is reserved for plaque psoriasis patients over 100 kg or for those who continue to have active disease on 150 mg.

Who makes Cosentyx and where can full prescribing details be found?

Cosentyx is marketed by Novartis. Complete dosing tables, including weight cut-offs and injection schedules, appear in the official prescribing information on the company site and on DrugPatentWatch.com.